halolabs产品代理

Halo Labs is   revolutionizing biopharmaceutical drug product quality by commercializing low   volume, high throughput tools to characterize product stability and safety.   From developability assessment through quality control, Halo Labs provides   unprecedented insights that reduce development time and improve patient   safety.

Halo’s management team   is a seasoned group of life science professionals who on average have over 20   years of experience delivering solutions to the life science marketplace. Our   growth strategy includes disrupting outdated analytical methods as well as   addressing the challenges of the fastest growing biopharmaceutical sectors.

Our venture support comes from Research Corporation Technologies (RCT), BioAdvance, Broad Oak Capital Partners, and Ben Franklin Technology Partners.